37 phenotypes from 6 alleles in 14 genetic backgrounds

Allelic Composition Genetic Background	Annotated Term	Reference
Cd19tm1(cre)Cgn/Cd19+ Gt(ROSA)26Sortm2(Cd74/MOG)Awai/Gt(ROSA)26Sor+ involves: 129P2/OlaHsd * C57BL/6	abnormal B cell physiology	J:140751
	decreased susceptibility to experimental autoimmune encephalomyelitis	J:140751
Cd74em1(IMPC)H/Cd74em1(IMPC)H C57BL/6N-Cd74em1(IMPC)H/H	decreased lymphocyte cell number	J:211773
	increased eosinophil cell number	J:211773
	increased monocyte cell number	J:211773
	increased neutrophil cell number	J:211773
Cd74tm1Doi/Cd74tm1Doi either: (involves: 129/Sv * B10.BR) or (involves: 129/Sv * C57BL/6)	abnormal antigen presentation	J:4119
	abnormal level of surface class II molecules	J:45185
	decreased CD4-positive, alpha-beta T cell number	J:4119, J:45185
	increased CD8-positive, alpha-beta T cell number	J:4119
Cd74tm1Doi/Cd74tm1Doi involves: 129S2/SvPas	abnormal dendritic cell antigen presentation	J:151699
Cd74tm1Eae/Cd74tm1Eae B6.129S2-Cd74tm1Eae	abnormal lymph node cell ratio	J:112084
	arrested B cell differentiation	J:112084
Cd74tm1Eae/Cd74tm1Eae involves: 129S2/SvPas	abnormal level of surface class II molecules	J:65917
	decreased B cell proliferation	J:113050, J:132865
	decreased CD4-positive, alpha-beta T cell number	J:113050
	decreased cell proliferation	J:147772
	decreased IgM level	J:113050
Cd74tm1Eae/Cd74tm1Eae involves: 129S2/SvPas * C57BL/6	increased myocardial infarct size	J:213776
	increased susceptibility to myocardial ischemic injury	J:213776
Cd74tm1Liz/Cd74+ involves: 129S/SvEv	normal hematopoietic system phenotype	J:155870
Cd74tm1Liz/Cd74tm1Liz B6.129S-Cd74tm1Liz	abnormal antigen presentation	J:125654
	abnormal antigen presentation via MHC class II	J:28966
	abnormal level of surface class II molecules	J:28966
	abnormal T-helper 1 physiology	J:125654
	decreased CD4-positive, alpha-beta T cell number	J:28966
	decreased susceptibility to experimental autoimmune encephalomyelitis	J:125654
	decreased susceptibility to type IV hypersensitivity reaction	J:125654
	decreased T cell proliferation	J:28966
	defective assembly of class II molecules	J:28966
Cd74tm1Liz/Cd74tm1Liz B6.129S-Cd74tm1Liz/J	decreased B cell number	J:194664
Cd74tm1Liz/Cd74tm1Liz involves: 129S/SvEv	abnormal positive T cell selection	J:125548
	normal hematopoietic system phenotype	J:155870
Cd74tm1Liz/Cd74tm1Liz involves: 129S/SvEv * BALB/c * C57BL	abnormal antigen presentation via MHC class II	J:110927
	abnormal B cell differentiation	J:110927
	abnormal dendritic cell antigen presentation	J:110927
	abnormal T cell proliferation	J:110927
	increased immature B cell number	J:110927
Cd74tm1Liz/Cd74tm1Liz involves: 129S/SvEv * BALB/cAn	abnormal antigen presentation via MHC class II	J:110927, J:113714
	abnormal B cell differentiation	J:110927
	abnormal dendritic cell antigen presentation	J:110927
	abnormal professional antigen presenting cell physiology	J:113714
	decreased CD4-positive, alpha-beta T cell number	J:110927, J:113714
	increased immature B cell number	J:110927
Cd74tm1Liz/Cd74tm1Liz involves: 129S/SvEv * C57BL * C57BL/10 * C57BR	abnormal antigen presentation via MHC class II	J:110927
	abnormal B cell differentiation	J:110927
	abnormal dendritic cell antigen presentation	J:110927
	abnormal T cell proliferation	J:110927
	increased immature B cell number	J:110927
Cd74tm1Liz/Cd74tm1Liz involves: 129S/SvEv * C57BL/6	abnormal antigen presentation via MHC class II	J:111565
Cd74tm1Liz/Cd74tm1Liz involves: 129S/SvEv * C57BL/6J	abnormal antigen presentation	J:72243
	abnormal antigen presentation via MHC class II	J:65918
	abnormal level of surface class II molecules	J:65918
	cachexia	J:65918
	decreased body size	J:65918
	decreased CD4-positive, alpha-beta T cell number	J:65918
	decreased interferon-gamma secretion	J:72243
	decreased susceptibility to experimental autoimmune encephalomyelitis	J:72243
	decreased T cell proliferation	J:72243
	defective assembly of class II molecules	J:65918
Cd74tm2Liz/Cd74tm1Liz involves: 129S/SvEv * C57BL/6	abnormal antigen presentation via MHC class II	J:28966
	normal immune system phenotype	J:28966
	increased T cell proliferation	J:28966
Cd74tm2Liz/Cd74tm2Liz involves: 129S/SvEv * C57BL/6	decreased interleukin-2 secretion	J:72243
	increased susceptibility to experimental autoimmune encephalomyelitis	J:72243